Stockscreener 앱 받기
4.24
1.63%
-0.07
전일 마감가:
$4.31
열려 있는:
$4.28
하루 거래량:
55,268
Relative Volume:
0.27
시가총액:
$148.86M
수익:
-
순이익/손실:
$-28.30M
주가수익비율:
-3.5041
EPS:
-1.21
순현금흐름:
$-21.30M
1주 성능:
-11.85%
1개월 성능:
+8.16%
6개월 성능:
+114.14%
1년 성능:
-43.16%
1일 변동 폭
$4.01
$4.40
1주일 범위
$4.01
$4.94
52주 변동 폭
$1.60
$7.89
Genelux Corp Stock (GNLX) Company Profile
명칭
Genelux Corp
전화
805-267-9889
주소
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE
GNLX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GNLX
Genelux Corp
|
4.27 | 148.86M | 0 | -28.30M | -21.30M | -1.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
478.88 | 121.85B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.20 | 76.83B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
620.39 | 37.96B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.82 | 30.69B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
269.38 | 29.71B | 3.32B | -860.46M | -1.04B | -8.32 |
Genelux Corp Stock (GNLX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-29 | 개시 | Guggenheim | Buy |
| 2024-08-28 | 개시 | ROTH MKM | Buy |
| 2023-11-27 | 개시 | H.C. Wainwright | Buy |
| 2023-09-12 | 개시 | Maxim Group | Buy |
| 2023-02-15 | 개시 | The Benchmark Company | Speculative Buy |
Genelux Corp 주식(GNLX)의 최신 뉴스
D.A. Davidson & CO. Makes New $51,000 Investment in Genelux Co. (NASDAQ:GNLX) - Defense World
Apollon Wealth Management LLC Grows Stock Holdings in Genelux Co. (NASDAQ:GNLX) - Defense World
Genelux Corporation (NASDAQ:GNLX) Announces CFO Transition and Appointment of New CFOGenelux Corporation, a leading biotechnology company, recently disclosed in an SEC filing that Lourie Zak has resigned as Chief Financial Officer, effective imm - Defense World
Genelux Corporation Announces Matt Pulisic Serves as Principal Financial Officer and Principal Accounting Officer - Marketscreener.com
Genelux appoints new CFO as Lourie Zak departs - MSN
Genelux Corporation Announces New Chief Financial Officer - Markets Insider
Genelux appoints new CFO amid clinical advancements - Investing.com
Genelux Corp. Appoints New CFO Amid Leadership Change - TipRanks
Genelux Names Matthew Pulisic as CFO -February 03, 2025 at 10:40 am EST - Marketscreener.com
Oncolytic Viruses Market Expected to rise, 2034 | Targovax, Replimune, Genelux Corporation, Candel Therapeutics, DNAtrix, SillaJen, Treovir, Lokon Pharma AB, Istari Oncology, CG Oncology, Amgen - Barchart
Genelux (GNLX) Stock Price, News & Analysis - MarketBeat
We Think Genelux (NASDAQ:GNLX) Needs To Drive Business Growth Carefully - Yahoo Finance
Could Genelux's Olvi-Vec Emerge As A Powerful Tool In The Fight Against Difficult-to-treat Cancers? - RTTNews
Geode Capital Management LLC Has $749,000 Position in Genelux Co. (NASDAQ:GNLX) - Defense World
Genelux director Tyree James L sells shares worth $8,511 - Investing.com India
Genelux director Tyree James L sells shares worth $8,511 By Investing.com - Investing.com Nigeria
XTX Topco Ltd Invests $59,000 in Genelux Co. (NASDAQ:GNLX) - Defense World
Genelux VP sells shares worth $14,742 By Investing.com - Investing.com Australia
Genelux CFO Zak Lourie sells $4,921 in stock By Investing.com - Investing.com Australia
Genelux's head of regulatory sells $5,873 in stock By Investing.com - Investing.com Australia
Genelux CFO Zak Lourie sells $4,921 in stock - Investing.com
Genelux CEO Zindrick Thomas sells $33,497 in stock - Investing.com
Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright - Yahoo Finance
HC Wainwright Cuts Genelux (NASDAQ:GNLX) Price Target to $30.00 - Defense World
Genelux shares target cut, maintains buy rating on 3Q earnings - Investing.com
Genelux reports Q3 EPS (19c), consensus (19c) - TipRanks
These 2 “Strong Buy” Penny Stocks Are Set to Triple (or more), Say Analysts - TipRanks
Genelux Corporation Reports Third Quarter 2024 Financial Results and Provides General Business Updates - GlobeNewswire
Genelux Corp. Releases New Corporate Presentation - TipRanks
Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference - Yahoo Finance
Genelux CEO to Present at Guggenheim Healthcare Innovation Conference - StockTitan
Individual investors who hold 56% of Genelux Corporation (NASDAQ:GNLX) gained 34%, institutions profited as well - Yahoo Finance
Guggenheim Begins Coverage on Genelux (NASDAQ:GNLX) - Defense World
Guggenheim sees upside in Genelux shares, targets $8 as pivotal cancer trial progresses - Investing.com India
Brokerages Set Genelux Co. (NASDAQ:GNLX) PT at $22.33 - MarketBeat
Highbridge Capital Management LLC Acquires Significant Stake in Genelux Corp - Yahoo Finance
Genelux doses first subject in Phase II trial of NSCLC treatment - Yahoo Finance
Genelux advances NSCLC treatment with Phase 2 Olvi-Vec trial - Investing.com
Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer - Yahoo Finance
Cubist Systematic Strategies LLC Takes $56,000 Position in Genelux Co. (NASDAQ:GNLX) - Defense World
Genelux Co. (NASDAQ:GNLX) Shares Sold by Renaissance Technologies LLC - Defense World
Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit - Yahoo Finance
Genelux announces executive departure By Investing.com - Investing.com Australia
Genelux announces executive departure - Investing.com
Point72 Asia Singapore Pte. Ltd. Acquires Shares of 20,162 Genelux Co. (NASDAQ:GNLX) - Defense World
Affinity Asset Advisors LLC Acquires New Position in Genelux Co. (NASDAQ:GNLX) - Defense World
Highbridge Capital Management LLC Invests $1.23 Million in Genelux Co. (NASDAQ:GNLX) - Defense World
Short Interest in Genelux Co. (NASDAQ:GNLX) Decreases By 7.3% - MarketBeat
Genelux Corp (GNLX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.33%
0.62%
자본화:
|
볼륨(24시간):